Antibody-dependent enhancement of human immunodeficiency virus type 1 infection.

Display options

Format

Share it on

Full text links

Lancet. 1988 Apr 09;1(8589):790-4. doi: 10.1016/s0140-6736(88)91657-1.

Antibody-dependent enhancement of human immunodeficiency virus type 1 infection.

Lancet (London, England)

W E Robinson, D C Montefiori, W M Mitchell

Affiliations

Vanderbilt University School of Medicine, Department of Pathology, Nashville, Tennessee 37232.

PMID: 2895317 DOI: 10.1016/s0140-6736(88)91657-1

Abstract

Two components of human serum enhance human immunodeficiency virus type 1 (HIV-1) infection and mask HIV-1 neutralising antibody activity. The first is heat-stable, unique to HIV-1 seropositive sera, and is removed by protein-A chromatography. The second is heat-labile and ubiquitous; it is found in normal serum and is removed by heating at 60 degrees C for 1 h or by treatment with cobra venom anticomplementary protein. Additionally, complement component C3 deficient serum lacks the labile activity although Clq deficient serum contains the labile factor. The data suggest that the two components are antibody and the alternative pathway of complement fixation. The mechanism of action does not involve an increase in either complement-mediated cytolysis or syncytium formation. The activity has been identified in 11 of 16 patients tested to date.

Cited by

Conserved HIV Epitopes for an Effective HIV Vaccine.

Sahay B, Nguyen CQ, Yamamoto JK.
J Clin Cell Immunol. 2017 Aug;8(4). doi: 10.4172/2155-9899.1000518. Epub 2017 Aug 30.
PMID: 29226015

FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge.

Miller C, Emanuelli M, Fink E, Musselman E, Mackie R, Troyer R, Elder J, VandeWoude S.
NPJ Vaccines. 2018 Apr 30;3:16. doi: 10.1038/s41541-018-0051-y. eCollection 2018.
PMID: 29736270

Mucosal AIDS virus transmission is enhanced by antiviral IgG isolated early in infection.

Marasini B, Vyas HK, Lakhashe SK, Hariraju D, Akhtar A, Ratcliffe SJ, Ruprecht RM.
AIDS. 2021 Dec 01;35(15):2423-2432. doi: 10.1097/QAD.0000000000003050.
PMID: 34402452

ACE2 can act as the secondary receptor in the FcγR-dependent ADE of SARS-CoV-2 infection.

Wang Z, Deng T, Zhang Y, Niu W, Nie Q, Yang S, Liu P, Pei P, Chen L, Li H, Cao B.
iScience. 2022 Jan 21;25(1):103720. doi: 10.1016/j.isci.2021.103720. Epub 2021 Dec 31.
PMID: 35005526

ACE2 can act as the secondary receptor in the FcγR-dependent ADE of SARS-CoV-2 infection.

Wang Z, Deng T, Zhang Y, Niu W, Nie Q, Yang S, Liu P, Pei P, Chen L, Li H, Cao B.
iScience. 2021 Dec 31;103720. doi: 10.1016/j.isci.2021.103720. Epub 2021 Dec 31.
PMID: 35005526

The potential of COVID-19 patients' sera to cause antibody-dependent enhancement of infection and IL-6 production.

Shimizu J, Sasaki T, Yamanaka A, Ichihara Y, Koketsu R, Samune Y, Cruz P, Sato K, Tanga N, Yoshimura Y, Murakami A, Yamada M, Itoi K, Nakayama EE, Miyazaki K, Shioda T.
Sci Rep. 2021 Dec 09;11(1):23713. doi: 10.1038/s41598-021-03273-0.
PMID: 34887501

Complement Evasion Strategies of Viruses: An Overview.

Agrawal P, Nawadkar R, Ojha H, Kumar J, Sahu A.
Front Microbiol. 2017 Jun 16;8:1117. doi: 10.3389/fmicb.2017.01117. eCollection 2017.
PMID: 28670306

Non-Neutralizing Antibodies Directed against HIV and Their Functions.

Mayr LM, Su B, Moog C.
Front Immunol. 2017 Nov 20;8:1590. doi: 10.3389/fimmu.2017.01590. eCollection 2017.
PMID: 29209323

Which Antibody Functions are Important for an HIV Vaccine?.

Su B, Moog C.
Front Immunol. 2014 Jun 18;5:289. doi: 10.3389/fimmu.2014.00289. eCollection 2014.
PMID: 24995008

The potential of COVID-19 patients' sera to cause antibody-dependent enhancement of infection and IL-6 production.

Antibody-dependent enhancement of human immunodeficiency virus type 1 infection.

Affiliations

Abstract

Cited by

Substances

MeSH terms

Publication Types

LinkOut - more resources